How to Legally Sell Cosmetic Ingredients in the EU

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab
COver

Table of Contents

Introduction: Selling Cosmetic Ingredients in the EU

Selling cosmetic ingredients in the EU legally can be a tricky problem for new comers in the market, especially for those companies outside the EU. The European Union (EU) stands as one of the world’s most demanding and rewarding markets for cosmetic ingredients. Renowned for its stringent regulations, the EU market is not for the faint-hearted but offers unparalleled opportunities for those who can navigate its complex landscape. Whether you are dealing with specialized ingredients like biosynthetic peptides or more traditional elements, understanding these regulations is crucial. This article aims to be your comprehensive guide, laying out the steps you need to take to ensure that your cosmetic ingredient complies with EU laws, thereby unlocking the immense potential of this market.

The Taiwan-EU Relationship

As a Taiwan-based company looking to enter the EU market, understanding the economic and trade relationships between Taiwan and the European Union is critical. Taiwan may not be an EU member state, but it has a robust trade relationship with the EU, often serving as a springboard to broader international markets. Ensuring that your products adhere to EU regulations will not only facilitate access to European markets but also enhance your brand’s credibility on a global scale.

EU flag

 

The Regulatory Landscape: An Overview

When it comes to governing cosmetic products and their ingredients, EU Regulation (EC) No 1223/2009 serves as the cornerstone. This regulation places an array of requirements on manufacturers, such as preparing a product safety report and notifying the EU Cosmetic Products Notification Portal (CPNP) before market placement. Additionally, it outlines stringent labeling requirements and provides a list of banned and restricted substances that all suppliers must adhere to. It’s worth noting that this regulation is continually updated, making ongoing compliance monitoring crucial for long-term success.

Definition of Natural Ingredients

One question that often arises is, “What exactly constitutes a natural ingredient?” According to the EU, natural ingredients are generally derived from plant, animal, or mineral sources. However, the lack of a universally accepted definition often creates room for interpretation, particularly for specialized ingredients like peptides. As such, it’s crucial to consult with legal experts and regulatory bodies to clarify the status of your ingredient.

 

Is Your Ingredient Natural or Non-Natural?

The classification of your ingredient as natural or non-natural can significantly impact your approach to the EU market. For example, peptides are indeed short chains of amino acids found in proteins across various food sources. However, their biosynthetic nature could categorize them as non-natural, which would subject them to a different set of regulations and scrutiny.

Steps for Natural Ingredients

For ingredients considered natural, the following steps are usually sufficient:

  1. Product Safety Report: Prepare a comprehensive safety report that includes your ingredient’s toxicological profile, allergen content, and other safety data.
  2. CPNP Notification: Notify the EU Cosmetic Products Notification Portal before your product enters the EU market.
  3. Labeling: Ensure your labels comply with EU standards, including listing all ingredients and their functions.
  4. Responsible Person: Appoint a responsible person within the EU to manage compliance obligations. This person acts as your local representative and takes on legal responsibilities.
  5. Quality Certifications: Acquiring additional certifications like Sedex, FairTrade, or COSMOS can also provide a competitive edge, particularly when targeting niche markets that prioritize such labels.

Small-Scale Producers

For those who are small-scale producers, particularly those manufacturing less than a ton per year, it’s worth noting that the EU does offer some exemptions and simplified processes. However, the core requirements related to safety and labeling are not relaxed. Therefore, even if your operation is on a smaller scale, you’re not exempt from these critical aspects of compliance. Preparing a product safety report and ensuring accurate labeling are non-negotiable steps you’ll need to undertake.

Additional Steps for Non-Natural Ingredients

For ingredients like biosynthetic peptides considered non-natural, additional steps are often required:

  1. Scientific Evaluation: Accumulate extensive scientific evaluations and safety data to prove the ingredient’s efficacy and safety.
  2. REACH Registration: Depending on the volume of production, you may need to register your ingredient under REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals).
  3. Ingredient Assessment: Ensure your ingredient is not listed under prohibited substances and complies with all restrictions.
  4. Transparency: Be transparent with buyers by providing them all necessary safety data and studies.
  5. Marketing and Labeling: Avoid misleading terms like “natural” in your marketing language to maintain integrity and adhere to regulations.

The Role of INCI

Having an International Nomenclature Cosmetic Ingredient (INCI) name for your ingredient is not just a formality but a crucial step in gaining market acceptance. INCI names are universally recognized and provide a standardized identity for the ingredient, which can be essential for global business operations. For companies based outside of the European Union, like those in Taiwan, possessing an INCI name can significantly expedite the market entry process by instilling a sense of credibility and assurance among buyers and regulatory bodies. It’s an important part of your ingredient’s ‘passport’ to the European market and beyond.

 

The Case for Niche Markets

Organic, natural, and fair-trade markets may be niche, but they are becoming increasingly significant. These markets have their own set of certification standards, but some of them allow for a percentage of non-natural ingredients, provided the overall product meets their criteria. Therefore, if your biosynthetic peptide or other specialized ingredient offers unique benefits, it could still find a home in these niche markets. This opens up a realm of opportunities to market your product as a premium ingredient with specialized benefits.

Consumer Trends

The evolving consumer trends in the European Union increasingly value transparency, ethical sourcing, and sustainability. Adhering to these values does more than just help with regulatory compliance; it significantly impacts consumer acceptance and brand reputation. In today’s market, consumers are more educated and discerning than ever before. They are likely to scrutinize specialized ingredients, and any steps you take towards greater transparency and sustainability will serve you well in gaining their trust.

 

Future Developments: Sustainability and Corporate Responsibility

Looking ahead, the EU is making significant strides towards sustainability with initiatives like the European Green Deal and the Corporate Sustainability Directive. While these initiatives primarily impact European companies, their ripple effect extends to suppliers in other countries who are part of the EU supply chain. As such, aligning your practices with these sustainability goals not only makes good business sense but could soon become a requirement for market access.

Legal Consultation

One aspect often overlooked by companies eager to enter the European market is the need for specialized legal consultation. The regulatory landscape is not only complex but also subject to interpretation and change. A legal team well-versed in the nuances of EU cosmetic regulations can be an invaluable asset. They can help navigate the complexities and avoid any costly mistakes or violations that could severely impact your market entry and long-term success.

 

Conclusion of Selling Cosmetic Ingredients in the EU

Navigating the labyrinthine regulatory landscape of the EU can be a daunting task, but the rewards for those who master it are considerable. Whether your ingredient is natural or not, a deep understanding of and strict adherence to EU regulations will set you on the path to success. With meticulous preparation, ongoing compliance efforts, and a willingness to adapt to future developments, you can ensure that your cosmetic ingredient not only enters the EU market but thrives in it. And if you also have a question about Selling Cosmetic Ingredients in the EU, please contact us to discuss!

 

ICPPX: A Revolutionary Ingredient for a Broad User Group

Beyond the cosmetic sphere, ICPPX serves a diverse User Group with conditions ranging from Osteoarthritis and Degenerative Arthritis to Tendon Fasciitis, Ligamentitis, and Muscle Ache. Its versatility also extends to treating Sprains and Blood Stasis, making it a truly multi-functional ingredient. Created through cutting-edge biosynthetic processes, ICPPX has an officially recognized INCI name and complies with EU regulations. Whether you’re a cosmetic manufacturer or a healthcare provider dealing with musculoskeletal issues, ICPPX’s broad application and compliance make it a compelling choice for the European market.

 

References

  1. EU Regulation (EC) No 1223/2009
  2. REACH Regulations
  3. EU Cosmetic Ingredient Database (CosIng)

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

你的消炎藥只是在「關掉煙霧探測器」?從源頭阻斷慢性發炎的胜肽科學

為什麼你的疲倦與疼痛總是反覆發作? 你是不是經常覺得關節痠痛、莫名疲倦,或者有各種過敏和腸胃問題,卻始終找不出確切原因 ? 在現代高壓與快節奏的生活中,許多人都在尋求這些亞健康狀態的解藥。事實上,現代人90%的慢性病,其實都來自同一個源頭:你體內有一把撲不滅的「無名火」,醫學上稱之為「慢性發炎」 。 當面臨這些不適,多數人的第一反應是服用非類固醇消炎藥(NSAIDs)或類固醇。然而,這些傳統藥物往往只能提供短暫的舒緩,一旦停藥,症狀便會捲土重來。這不禁讓我們反思:我們是否只在處理表面症狀,而忽略了真正的問題根源?   傳統消炎藥的盲點與機制 要理解傳統藥物的局限性,我們必須先了解發炎的運作機制。當身體受到外界刺激時,免疫系統中的「巨噬細胞」會釋放 TNF-α 和 IL-1β 等發炎細胞因子 。這本是身體為了防禦而響起的警報器,但當免疫系統失衡,這些發炎因子便會失控形成「細胞因子風暴」,開始無差別攻擊正常細胞、黏膜和關節,甚至破壞 DNA 。 傳統的西藥如 NSAIDs 是如何運作的呢?它們主要的作用機制是抑制下游的 COX-1 或 COX-2 酵素 。 為了讓大家更直觀地理解,我們可以比較一下這兩種機制的差異:

Read More
公司最新訊息

止痛藥的隱形代價:淨火肽如何透過「8小時降解」機制重塑無毒抗炎新標準?

引言 在現代高壓的生活節奏中,面對關節痠痛或慢性疲勞,多數人的第一反應往往是去藥房購買非類固醇消炎止痛藥,或是服用醫生開立的類固醇 。當藥效發揮,疼痛的警報聲停止,我們便誤以為身體恢復了健康 。 然而,你吞下的那顆止痛藥,在讓你感覺不到痛之後,究竟去了哪裡? 這是一個多數消費者忽略,而品牌研發端必須正視的痛點。傳統藥物在體內的作用機制,實際上只是粗暴地抑制了下游的 COX 酵素 。這就像是一群莽漢直接砸爛了火災警報器,卻對真正引發火災的源頭無能為力 。更嚴重的是,這些無法被身體完全辨識與利用的化學合成物,在完成掩蓋任務後並不會憑空消失,而是轉化為化學廢棄物 。 這些殘留物迫使肝臟超負荷運作以進行代謝,同時也讓腎臟拼命處理排毒 。由於 COX 酵素被過度抑制,人體保護胃壁的機制隨之停擺,最終導致腸胃黏膜逐漸受到破壞 。這不是真正的治療,而是一場用內臟健康換取短暫不痛的恐怖交易 。身為保健或保養品牌的決策者,我們必須思考:除了這種「拆東牆補西牆」的化學療法,我們能否為市場提供一種更安全、無毒的解答?   核心機制深潛 為了解決傳統消炎藥物的瓶頸,富比積生物科技(AHB Lab)突破傳統藥理學限制,研發出名為「淨火肽 Healtide®」的第三代生物合成定序胜肽 。這項技術透過「生物黑客」的思維,重新定義了抗炎機制的標準。   1.

Read More
公司最新訊息

你體內的「無名火」正在搞破壞!一招從源頭撲滅慢性發炎(淨火肽 Healtide® 機理大解密)

為什麼吃了消炎藥,身體的「火」還是滅不掉? 你是否經常遇到這樣的客戶反饋:消費者面對關節痠痛、過敏、腸胃不適或皮膚慢性暗沉,長期服用非類固醇消炎藥(NSAIDs)或塗抹類固醇,卻總是反覆發作、治標不治本 ?   現代醫學與功能生物學證實:90% 的慢性疾病與老化瓶頸,核心源頭都來自體內撲不滅的「慢性發炎」。 傳統生技產品或化學藥物的開發邏輯,大多著眼於抑制下游的 COX-1 或 COX-2 酵素 。用一個心智模型(Mental Model)來比喻:這就像火災發生時,你只是跑去「關掉煙霧探測器」,卻根本沒有沒收那個正在不斷點火的「打火機」! 長期下來,不僅無法根除發炎,化學藥物更可能增加肝腎與腸胃道的代謝負擔 。 市場正在尋找一種更高訊噪比、能「從源頭斷火」且安全無副作用的革命性生物素材。這正是富比積生物科技(AHB Lab)董事長莊國昇博士與研發團隊,成功推出第三代生物合成定序胜肽——淨火肽(Healtide®)的契機 。   淨火肽(Healtide®)的源頭阻斷機制 當人體受到刺激時,免疫系統的「巨噬細胞」會釋放 TNF-α(腫瘤壞死因子)與 IL-1β 等發炎細胞因子 。一旦失控,就會引發無差別攻擊正常組織的「細胞因子風暴」

Read More